UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): ~~January~~March 2619, 2016

Commission file number: 000-54072

China Ginseng Holdings, Inc.

(Exact name of registrant as specified in its charter)

Nevada		20-3348253
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

Nevada

(State or other jurisdiction of
incorporation or organization)

64 Jie Fang Da Road

Ji Yu Building A, Suite 1208

Changchun City, China

(Address of principal executive offices)

Registrant’s telephone (01186) 43185790039

64 Jie Fang Da Road Ji Yu Building A, Suite 1208 Changchun City, China		130022
(Address of principal executive offices)		(Zip Code)

Copies to:

~~Registrant’s~~Hunter ~~telephone~~Taubman ~~(01186)~~Fischer ~~43185790039~~LLC

~~Copies to: Hunter Taubman Fischer LLC~~ 1450 Broadway, 26th Floor ~~New York, NY 10018 Tel: 212-732-7184~~

New York, NY 10018

Tel: 212-732-7184

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Section 5 – Corporate Governance and Management

Item 5.02: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

On March ~~January 26~~21, ~~2017~~2016, Mr. ~~Guoqin~~Xiaohua ~~Yin~~Cai tendered his resignation to China Ginseng Holdings, Inc. (the “Company”) as the ~~Company’s~~Chief Marketing ~~Chairman,~~Officer ~~Director~~(“CMO”) ~~and~~of ~~Chief Executive~~the ~~Officer~~Company. Mr. ~~Yin~~Cai’s resignation did not result from any disagreement regarding any matter related to the Company’s operations, policies or practices.

On the same day, the Company’s Board of Directors accepted Mr. ~~Yin~~Cai’s resignation and simultaneously appointed MrMs. ~~Long~~Xiaolin Li He as its ~~Chairman,~~CMO ~~Director~~ and Ms. Baolan Wu as its Chief ~~Executive~~ Operations Officer (COO).

MrMs. Li He has extensive experience in ~~green~~marketing ~~and organic~~industry. ~~agriculture~~Ms. ~~and~~Li ~~food~~had &been ~~restaurant~~the ~~industry.~~marketing ~~Mr.~~director Heof isRenlongxiang anpharmaceutical ~~owner~~Heilong Jiang ofProvince afrom ~~green~~2003 ~~organic~~to ~~agricultural~~2015. ~~entity,~~Ms. ~~Fujing~~Li ~~Lifeng Rice~~graduated ~~Cooperatives,~~from ~~which~~Jiamusi ~~was~~University ~~incorporated~~ in ~~2009~~1994 ~~and~~with ~~operates~~a ~~under~~bachelor adegree ~~cooperation~~and ~~agreement~~major ~~with~~in ~~Suibin~~Chinese Language. ~~County~~Ms. ~~Government~~Wu ofhas ~~Heilongjian Province~~extensive experience in ~~China~~pharmaceutical industry and anaccounting ~~owner~~experience. Ms. Wu had been the CFO of aHeilongjiang Wanchong ~~restaurant~~Pharmaceutical Co., ~~LongHe~~Ltd ~~Grill,~~from ~~opened~~October in1993 ~~2004~~to inMay ~~Jiamusi~~2013 ~~City,~~and ~~Heilongjian~~she ~~Province~~had ~~which~~been ~~later became~~General aManager ~~chain~~of ~~restaurant~~Xingcheng inHeilongjiang ~~China~~from May in2013 ~~2007~~to March 2016. MrMs. HeWu graduated from ~~Shijiazhuang~~Heilongjiang ~~Huabei~~Commercial ~~Medical~~Institute ~~College~~ in ~~2000~~1988 with ana ~~associate~~ bachelor degree and major in ~~clinical care~~accounting.

We are currently negotiating the terms of MrMs. He Li and Ms. Wu’s employment ~~agreement~~agreements, and will file a copy of the agreement when it becomes available.

~~SIGNATURES~~Item 7.01 Regulation FD Disclosure.

~~Pursuant~~On March to19, 2016, the ~~requirements~~company ofhosted ~~the Securities~~a ~~Exchange~~conference ~~Act~~at ofwhich ~~1934,~~they ~~this~~did ~~report~~a ~~has~~presentation ~~been~~about ~~signed~~their ~~below~~company byto the ~~following~~potential ~~persons~~distributers of onGinseng ~~behalf~~juice product and those investors of ~~the~~their ~~registrant~~new ~~and~~eye-protection ~~in the~~project. ~~capacities~~A ~~and~~copy onof ~~the~~CSNG ~~date~~Distributor ~~indicated~~Conference Presentation is attached hereto as Exhibit 99.1.

	China Ginseng Holdings, Inc.
Date: January 28, 2016	By:	/s/ Long He
		Long He Chief Executive Officer

Copies of CSNG Distributor Conference Presentation shall not be considered as an offer to sell or a solicitation of an offer to buy any securities of the company in any jurisdiction where the offer or sale is not permitted. In addition, such materials shall not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(a)-(c) Not applicable.

(d) Exhibits:

Exhibit No.	Description

99.1	CSNG Distributor Conference Presentation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

	China Ginseng Holdings, Inc.

Date: March 23, 2016	By:	/s/ Long He
		Long He Chief Executive Officer

Filing Compare · China Ginseng Holdings Inc